Literature DB >> 32189190

Impact of gender on immature platelet count and its relationship with coronary artery disease.

Federica Negro1, Monica Verdoia1,2, Francesco Tonon1, Matteo Nardin3, Elvin Kedhi4, Giuseppe De Luca5.   

Abstract

The impact of platelet parameters on the cardiovascular risk is still debated. Gender differences in platelet volume indexes and turnover have been previously reported, potentially conditioning their role in the development of coronary artery disease (CAD). However, few studies have addressed, so far, the impact of gender on the immature platelet fraction (IPF) and count (IPC) and their relationship with CAD. We enrolled consecutive patients undergoing coronary angiography in a single centre. IPF and platelet indexes were measured at admission. Significant CAD was defined as the presence of at least one coronary stenosis more than 50%. A total of 2550 patients were included, 1835 (72%) were males, and 715 (28%) were females. Female patients were older (p < 0.001), with lower BMI (p = 0.002), lower prevalence of active smoking (p < 0.001), previous MI, previous PCI and CABG (p = 0.001, p = 0.001, p < 0.001), whilst a higher prevalence of renal failure (p = 0.02), acute presentation (p < 0.001) and CAD (p < 0.001). Platelet count was higher in females (p < 0.001), as well as the IPC levels (838.38 ± 562.05 vs 792.24 ± 535.66, p = 0.05) with no difference in the levels of immature platelet fraction (3.67 ± 2.68% vs 3.74 ± 2.6%, p = 0.55) or the prevalence of patients with IPF ≥ 3rd tertile (33.7% vs 35.2%, p = 0.26). At multivariate analysis, after correction for baseline confounders, gender did not emerge as an independent predictor of higher IPF (adjusted OR [95% CI] = 0.82 [0.64-1.06], p = 0.13). When dividing our patients according to the levels of IPF, in women we observed an inverse association between IPF ≥ 3rd tertile and coronary calcifications (p = 0.025) and a higher prevalence of restenosis (p = 0.003), but no difference in CAD (65.6% vs 66.9%, p = 0.71) or severe CAD (28.1% vs 24.7%, p = 0.31). In males, the IPF ≥ 3rd tertile related with a lower TIMI flow (p = 0.001). Males with lower IPF had a significantly higher percentage of CAD (87.7% vs 83.3%, p = 0.007; adjusted OR: 0.699 [95% CI] = [0.54-0.91], p = 0.008) but not for severe CAD (36.5% vs 39.9%, p = 0.134). The present study shows that among patients undergoing coronary angiography, gender is not associated to the levels of immature platelet fraction. Moreover, we found no association between IPF and the prevalence and extent of CAD in female gender, whereas in male gender the IPF was inversely related with the prevalence of CAD.

Entities:  

Keywords:  Coronary artery disease; Gender; Immature platelet fraction; Reticulated platelets

Mesh:

Year:  2020        PMID: 32189190     DOI: 10.1007/s11239-020-02080-0

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  38 in total

1.  Impact of Long-Term Dual Antiplatelet Therapy on Immature Platelet Count and Platelet Reactivity.

Authors:  Monica Verdoia; Patrizia Pergolini; Roberta Rolla; Lucia Barbieri; Alon Schaffer; Paolo Marino; Giorgio Bellomo; Harry Suryapranata; Giuseppe De Luca
Journal:  Angiology       Date:  2017-10-29       Impact factor: 3.619

2.  Gender differences in time to presentation for myocardial infarction before and after a national women's cardiovascular awareness campaign: a temporal analysis from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress ADverse Outcomes with Early Implementation (CRUSADE) and the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network-Get with the Guidelines (NCDR ACTION Registry-GWTG).

Authors:  Deborah B Diercks; Kelly P Owen; Michael C Kontos; Andra Blomkalns; Anita Y Chen; Chadwick Miller; Stephen Wiviott; Eric D Peterson
Journal:  Am Heart J       Date:  2010-07       Impact factor: 4.749

3.  Safety and efficacy of biodegradable vs. durable polymer drug-eluting stents: evidence from a meta-analysis of randomised trials.

Authors:  Eliano Pio Navarese; Jacek Kubica; Fausto Castriota; C Michael Gibson; Giuseppe De Luca; Antonino Buffon; Leonardo Bolognese; Massimo Margheri; Felicita Andreotti; Carlo Di Mario; Stefano De Servi
Journal:  EuroIntervention       Date:  2011-12       Impact factor: 6.534

Review 4.  Gender differences in cardiovascular therapy: focus on antithrombotic therapy and percutaneous coronary intervention.

Authors:  Juan Luis Gutiérrez-Chico; Julinda Mehilli
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

5.  Sex-related differences in outcome after ST-segment elevation myocardial infarction treated by primary angioplasty: data from the Zwolle Myocardial Infarction study.

Authors:  Giuseppe De Luca; Harry Suryapranata; Jan-Henk Dambrink; Jan Paul Ottervanger; Arnoud W J van 't Hof; Felix Zijlstra; Jan C A Hoorntje; A T Marcel Gosselink; Menko-Jan de Boer
Journal:  Am Heart J       Date:  2004-11       Impact factor: 4.749

6.  Sex differences of leukocyte-platelet interactions and on-treatment platelet reactivity in patients with atherosclerosis.

Authors:  Thomas Gremmel; Christoph W Kopp; Beate Eichelberger; Renate Koppensteiner; Simon Panzer
Journal:  Atherosclerosis       Date:  2014-10-29       Impact factor: 5.162

7.  Thrombopoietin and mean platelet volume in coronary artery disease.

Authors:  H Senaran; M Ileri; A Altinbaş; A Koşar; E Yetkin; M Oztürk; Y Karaaslan; S Kirazli
Journal:  Clin Cardiol       Date:  2001-05       Impact factor: 2.882

8.  Reticulated platelets and antiplatelet therapy response in diabetic patients.

Authors:  Romana Mijovic; Nada Kovacevic; Marija Zarkov; Zoran Stosic; Velibor Cabarkapa; Gorana Mitic
Journal:  J Thromb Thrombolysis       Date:  2015-08       Impact factor: 2.300

9.  Circulating reticulated platelets over time in patients with myocardial infarction treated with prasugrel or ticagrelor.

Authors:  Alon Eisen; Hila Lerman-Shivek; Leor Perl; Eldad Rechavia; Dorit Leshem-Lev; Noa Zemer-Wassercug; Oshrat Dadush; Shirit Kazum; Pablo Codner; Ran Kornowski; Eli I Lev
Journal:  J Thromb Thrombolysis       Date:  2015-07       Impact factor: 2.300

Review 10.  Reticulated platelets: analytical aspects and clinical utility.

Authors:  Johannes J M L Hoffmann
Journal:  Clin Chem Lab Med       Date:  2014-08       Impact factor: 3.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.